SOURCES SOUGHT
68 -- This is a request for Information (RFI) Sources Sought (SS) for 50 vials of IND IV Pentostam (Sodium Stibogluconate)
- Notice Date
- 3/31/2015
- Notice Type
- Sources Sought
- NAICS
- 325412
— Pharmaceutical Preparation Manufacturing
- Contracting Office
- US Army Medical Research Acquisition Activity, ATTN: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014
- ZIP Code
- 21702-5014
- Solicitation Number
- W81XWH15T0168
- Response Due
- 4/7/2015
- Archive Date
- 5/30/2015
- Point of Contact
- Kimberly Hannan, 3016193490
- E-Mail Address
-
US Army Medical Research Acquisition Activity
(kimberly.s.hannan.civ@mail.mil)
- Small Business Set-Aside
- N/A
- Description
- 1.0 SUBJECT: This is a request for Information (RFI) Sources Sought (SS) ONLY. The U.S. Army Medical Research Acquisition Activity (USAMRAA) in support of the U.S. Army Medical Materiel Development Activity's (USAMMDA) mission to provide treatment to the Warfighter, this request for information is seeking entities interested in providing 50 vials of IND IV Pentostam (Sodium Stibogluconate). Pentostam is used to treat individuals who have acquired leishmaniasis (either cutaneous, mucocutaneous or visceral). The current protocol is written and approved by FDA specifically for Pentostam. The protocol is under Investigational New Drug application (IND) # 14,150. 2.0 DISCLAIMER: This RFI is issued solely for information and planning purposes and does not constitute a solicitation. Neither unsolicited proposals nor any other kind of offers will be considered in response to this RFI. Responses to this notice are not offers and will not be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. All information received in response to this RFI that is marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. At this time, questions concerning the composition and requirements for a future RFP will not be entertained. 3.0 DESCRIPTION: This request for information is seeking entities interested in providing 50 vials of IND IV Pentostam (Sodium Stibogluconate) for purchase. Purchase will either occur again when all product is used for treatment or product has expired. Product should have a two to three year expiration date from when product is acquired. 4.0 SUBMISSION INSTRUCTIONS: Entities interested in submitting a response must furnish in writing, a 2-3 page (not including cover page, index or list of references) synopsis of their capability to provide the described product, including any necessary lead time. Companies responding to this notice must provide complete contact information (telephone, address, email address). Responders must identify their company's business size (based on the NAICS size standard), business status (i.e. small business, disadvantaged, HUB zone, woman owned, service disabled veteran owned). Please also include information regarding any prior experience with U.S. Government contracts and favorable experience working with the FDA. 5.0 SUBMISSION CONTACT INFORMATION: Interested entities shall forward submissions to Kimberly Hannan at kimberly.s.hannan.civ@mail.mil no later than the close of business 07 April 2015. Telephonic communication will not be considered as submission or receive response.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/USAMRAA/DAMD17/W81XWH15T0168/listing.html)
- Place of Performance
- Address: US Army Medical Research Acquisition Activity ATTN: MCMR-AAA, 820 Chandler Street Frederick MD
- Zip Code: 21702-5014
- Zip Code: 21702-5014
- Record
- SN03684482-W 20150402/150331235320-65d9f9efbe61227523c6050791e49436 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |